Dan Hayes

Dan Hayes is a prominent figure in biomedical engineering and entrepreneurship. He is the co-founder of Illuminate Therapeutics, a startup developing innovative cancer treatments.1 Here are some key details about Dan Hayes:

Professional Background

• Current Position: Professor of Biomedical Engineering at Penn State University2
• Academic Leadership:
  • Department Head of Biomedical Engineering at Penn State (2022-present)
  • Director of the Center of Excellence in Industrial Biotechnology (2021-present)

Research and Innovation

Hayes is the principal investigator leading Illuminate Therapeutics, which is pioneering a groundbreaking treatment for head and neck cancers.1 Their technology, called Light Activated Drug Delivery and Release (LADDR), uses light-sensitive nanoparticles to deliver targeted cancer treatments.3

Entrepreneurial Experience

• Co-founder of Illuminate Therapeutics (2023-present)2
• Previously co-founded and served as President/CEO of NanoHorizons (2002-2008)2
• Has been involved in multiple university spin-outs and technology commercialization efforts4

Academic Career

• Joined Penn State as an Associate Professor in 2016
• Previously held faculty positions at Louisiana State University (2008-2016)2
• Obtained his PhD in Engineering Science and Mechanics from Penn State University2

Achievements and Recognition

• Illuminate Therapeutics won the $75,000 grand prize at the 2022 Invent Penn State Tech Tournament1
• Has authored over 100 peer-reviewed publications4
• Holds multiple patents in drug delivery and product development4

Dan Hayes's work exemplifies the intersection of academic research and entrepreneurship, with a focus on developing technologies that can have a significant impact on patient care, particularly in cancer treatment.